查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1698394

人工心臟瓣膜市场：未来预测（2025-2030）

Prosthetic Heart Valve Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计人工心臟瓣膜市场规模将从 2025 年的 87.6 亿美元成长至 2030 年的 144.4 亿美元，期间复合年增长率为 10.52%。

  • 心臟瓣膜疾病的盛行率不断上升，推动了心臟瓣膜的采用，从而推动了市场的成长。此外，医疗技术和治疗方法的进步提高了患者对诊断、治疗方案和替代方案的认识，进一步提升了市场前景。预计在预测期内，政府的支持性法规和医疗保健基础设施的改善也将有助于市场扩张。
  • 由于心血管疾病发生率高，北美占据了很大的市场份额，尤其是在美国，四分之一的死亡是由于心臟病造成的。同时，在人们健康意识不断增强和医疗保健投资不断增加的推动下，亚太地区有望实现强劲成长。
  • 全球心臟瓣膜假体市场报告对行业格局进行了详细分析，并提供了由资料驱动的预测和综合分析支持的策略和执行层面的见解。该报告定期更新，为决策者提供有关当前市场趋势、新商机和市场竞争力的可行资讯。它评估了各个领域的需求，例如产品类型（如机械心臟瓣膜和组织心臟瓣膜）以及主要最终用户类别（如医院/诊所、研究实验室等）。它还探讨了置换术和经导管瓣膜置换术等手术类型，并强调了这些领域的技术进步。此外，它还评估关键的政府政策、法规结构和宏观经济因素，以提供对市场生态系统的整体情况。

报告中介绍的主要企业包括波士顿科学公司、爱德华生命科学公司、雅培、美敦力、JenaValve Technology Inc.、Corcym Srl（LivaNova PLC）、CryoLife Inc.、Meril Life Sciences Pvt。 Ltd.、乐普医疗科技有限公司、TTK Healthcare Limited 和 Symetis SA。

本报告的主要优点

  • 深刻分析：获得涵盖主要地区和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透。
  • 市场驱动因素和未来趋势：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
  • 适用范围广：对于新兴企业、研究机构、顾问公司、中小企业和大型企业来说，它都是实用且具有成本效益的。

它有什么用途？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024）和预测资料（2025-2030）
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按部门和地区（国家）分類的收益成长和预测分析
  • 公司概况（策略、产品、财务资讯、主要趋势等）

人工心臟瓣膜市场细分

人工心臟瓣膜市场：依类型细分

  • 该报告按类型对市场进行细分如下：
  • 机械心臟瓣膜
  • 组织心臟瓣膜

人工心臟瓣膜市场：最终用户细分：

  • 该报告根据最终用户对市场进行以下细分：
  • 医院和诊所
  • 研究所
  • 其他的

人工心臟瓣膜：依手术类型细分

  • 该报告根据程序类型对市场进行细分，如下所示：
  • 外科瓣膜置换术
  • 经导管瓣膜置换术

人工心臟瓣膜市场：依地区细分

该报告还提供了针对人工心臟瓣膜市场的特定国家预测和分析，分为以下几个区域：

  • 北美（美国、加拿大、墨西哥）
  • 南美洲（巴西、阿根廷等）
  • 欧洲（德国、英国、法国、西班牙等）
  • 中东和非洲（沙乌地阿拉伯、阿联酋等）
  • 亚太地区（中国、日本、印度、韩国、泰国、印尼、世界其他地区）。

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 研究范围
  • 市场区隔

第三章 商业景气

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

第五章 人工心臟瓣膜市场（按类型）

  • 介绍
  • 人工心臟瓣膜
  • 组织心臟瓣膜

第六章 人工心臟瓣膜市场（依最终使用者）

  • 介绍
  • 医院和诊所
  • 实验室
  • 其他的

7. 人工心臟瓣膜市场（依手术类型）

  • 介绍
  • 外科瓣膜置换术
  • 经导管瓣膜置换术

8. 人工心臟瓣膜市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 台湾
    • 泰国
    • 印尼
    • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 企业合併、协议、商业合作
  • 竞争仪錶板

第十章 公司简介

  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Abbott
  • Medtronic
  • JenaValve Technology Inc.
  • Corcym Srl（LivaNova PLC）
  • CryoLife Inc
  • Meril Life Sciences Pvt. Ltd.
  • Lepu Medical Technology Co., Ltd
  • TTK Healthcare Limited
  • Symetis SA

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061610596

The prosthetic heart valve market will grow to US$14.44 billion in 2030 from US$8.76 billion in 2025 at CAGR of 10.52% during this period.

  • The increasing prevalence of valvular heart diseases is driving the adoption of heart valves, thereby fueling market growth. Additionally, advancements in medical technology and treatments have heightened patient awareness about diagnosis, treatment options, and alternatives, further boosting market prospects. Supportive government regulations and improvements in healthcare infrastructure are also expected to contribute to market expansion during the forecast period.
  • North America holds a significant share of the market, driven by high rates of cardiovascular diseases, particularly in the U.S., where heart disease accounts for 1 in every 4 deaths. Meanwhile, the Asia Pacific region is poised for robust growth, supported by rising health awareness and increased healthcare investments.
  • The global Prosthetic Heart Valve Market report provides a detailed analysis of the industry landscape, offering strategic and executive-level insights supported by data-driven forecasts and comprehensive analysis. Regularly updated, the report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. It evaluates demand across various segments, including product types such as Mechanical Heart Valves and Tissue Heart Valves, and key end-user categories like Hospitals and Clinics, Research Laboratories, and Others. The report also explores procedure types, such as Surgical Valve Replacement and Transcatheter Valve Replacements, highlighting technological advancements in these areas. Additionally, it assesses critical government policies, regulatory frameworks, and macroeconomic factors, providing a holistic perspective of the market ecosystem.

Some of the major players covered in this report include Boston Scientific Corporation, Edwards Lifesciences Corporation, Abbott, Medtronic, JenaValve Technology Inc., Corcym S.r.l. (LivaNova PLC), CryoLife Inc, Meril Life Sciences Pvt. Ltd., Lepu Medical Technology Co., Ltd, TTK Healthcare Limited, Symetis SA among others.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Prosthetic Heart Valve Market Segmentations:

Prosthetic Heart Valve Market Segmentation by type:

  • The market is analyzed by type into the following:
  • Mechanical Heart Valve
  • Tissue Heart Valve

Prosthetic Heart Valve Market Segmentation by end-user:

  • The report analyzes the market by end-user as below:
  • Hospitals and Clinics
  • Research Laboratories
  • Others

Prosthetic Heart Valve Market Segmentation by procedure type:

  • The market is analyzed by product type into the following:
  • Surgical Valve Replacement
  • Transcatheter Valve Replacements

Prosthetic Heart Valve Market Segmentation by regions:

The study also analyzed the Prosthetic Heart Valve Market into the following regions, with country-level forecasts and analysis as below:

  • North America (US, Canada, and Mexico)
  • South America (Brazil, Argentina, and Others)
  • Europe (Germany, UK, France, Spain and Others
  • Middle East and Africa (Saudi Arabia, UAE and Others)
  • Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PROSTHETIC HEART VALVE MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Mechanical Heart Valve
  • 5.3. Tissue Heart Valve

6. PROSTHETIC HEART VALVE MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals and Clinics
  • 6.3. Research Laboratories
  • 6.4. Others

7. PROSTHETIC HEART VALVE MARKET BY PROCEDURE TYPE

  • 7.1. Introduction
  • 7.2. Surgical Valve Replacement
  • 7.3. Transcatheter Valve Replacement

8. PROSTHETIC HEART VALVE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. Japan
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Boston Scientific Corporation
  • 10.2. Edwards Lifesciences Corporation
  • 10.3. Abbott
  • 10.4. Medtronic
  • 10.5. JenaValve Technology Inc.
  • 10.6. Corcym S.r.l. (LivaNova PLC)
  • 10.7. CryoLife Inc
  • 10.8. Meril Life Sciences Pvt. Ltd.
  • 10.9. Lepu Medical Technology Co., Ltd
  • 10.10. TTK Healthcare Limited
  • 10.11. Symetis SA

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations